Dopamine .beta.-hydroxylase inhibitors

Details Dopamine .beta.-hydroxylase inhibitors Dopamine .beta.-hydroxylase inhibitors

1985-04-16

1988-09-20

Hollrah, Glennon H.

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

548342, C07D23304

Patent

active

047727233

ABSTRACT:
Potent DBH Inhibitors having the formula: ##STR1## wherein R is --CO.sub.2 H or --CH.sub.2 NHR.sup.1 can be used to inhibit DBH activity in mammals.

REFERENCES:
patent: 3915980 (1975-10-01), Gebert et al.
patent: 4000079 (1976-12-01), Rasp et al.
Life Sciences vol. 12, Part II, pp. 417-423, Stolk & Hanlon 1973.
European Journal of Pharmacology, vol. 37, (1976) pp. 179-188, Claxton; Palfreyman, Poyser & Whiting.
Essays in Neurochemistry and Neuropharmacology, vol. 4, pp. 178-193, 1980 Youdim et al.
Goldstein, Pharmacol. Rev. 18(1), 77 (1966).
Hidaka et al., Mol. Pharmacol. 9, 172 (1973).
Fuller et al., Adv. Enzyme Regul. 15, 267 (1976).
Acta Chemica Scandinavica 21 (1967), pp. 279-283.
Beilstein Handbuch der Organischen Chemie, 25, Part 2, 1981, pp. 719-720.
Runti et al., Il Farmaco E. Sc. 36, 260 (1980).
Iverson et al., Acta Chem. Scand. 21, 279 (1967).

Affiliated with

Also associated with

Rating

Dopamine .beta.-hydroxylase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dopamine .beta.-hydroxylase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dopamine .beta.-hydroxylase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1749535